Metagenomi Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||
| Net Income | -16,133 | -43,593 | -21,442 |
| Depreciation Amortization | -1,392 | 290 | 590 |
| Accounts payable and accrued liabilities | 1,205 | N/A | N/A |
| Other Working Capital | -4,982 | 69,487 | 46,255 |
| Other Operating Activity | 307 | 3,540 | -1,146 |
| Operating Cash Flow | $-20,995 | $29,724 | $24,257 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -2,668 | -13,977 | -2,903 |
| Purchase Of Investment | -119,198 | N/A | N/A |
| Sale Of Investment | 49,798 | N/A | N/A |
| Other Investing Activity | 0 | -108,223 | -71,413 |
| Investing Cash Flow | $-72,068 | $-122,200 | $-74,316 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 4,295 | 239,594 | 39,922 |
| Financing Cash Flow | $4,295 | $239,594 | $39,922 |
| Beginning Cash Position | 190,514 | 43,396 | 53,533 |
| End Cash Position | 101,746 | 190,514 | 43,396 |
| Net Cash Flow | $-88,768 | $147,118 | $-10,137 |
| Free Cash Flow | |||
| Operating Cash Flow | -20,995 | 29,724 | 24,257 |
| Capital Expenditure | -2,668 | N/A | N/A |
| Free Cash Flow | -23,663 | 29,724 | 24,257 |